Sacramento, CA -- April 10, 2018 -- InvestorsHub NewsWire -- A
new report and video has been published on Innovest Global, Inc.
(OTC PINK: IVST). Innovest Global, Inc. is a diversified holding
company that focuses on acquiring niche, high-growth businesses
that are capable of generating significant annual revenue. The
company’s planned subsidiaries operate across telehealth, biotech,
commercial energy, business-to-business distribution, national call
center and auto sales.
The report provides an overview of Innovest Global, Inc., its
subsidiaries, financials, industry analysis and more. The content
also covers the global outlook for the healthcare sector.
Deloitte: 656 Million People Or 11.5% Of Global Population Is
Aged 65 Or Older
Technological advancements have aided humanity across all
aspects of our lives. One of the key benefits of greater
technological capabilities is ability to develop more effective
healthcare treatments. After all, health and wellness are key
components to any thriving civilization. Greater abilities to
extend human life can be witnessed through the statistic that 656
million people, or around 11.50% of total world population, is now
aged 65 years or older.
According to Deloitte’s 2018 Global Life Sciences
Outlook report, global healthcare spending is forecast to reach
$8.7 trillion by 2020, compared to $7 trillion in 2015. The market
research firm credits the spending increase on aging and expanding
populations, growing emerging markets, advancements in medical
technology, and rising labor costs.
However, the rising capabilities of medical technology are not
expected to stop the growth of ailments and deadly diseases. For
example, Deloitte estimates that diabetes will affect around 642
million people by 2040 thanks to rapid urbanization, diet changes,
increasingly sedentary lifestyles, and skyrocketing obesity
rates.
On a more positive note, medical technology (Medtech) is seen as
another strong area of the healthcare sector, which is forecast to
reach $521.9 billion by 2022. Overall, researchers see in virtro
diagnostics as the key driver and largest segment of medtech moving
forward.
According to the American Brain Tumor Association, an
estimated 80,000 new cases of primary brain tumors will be
diagnosed this year. Another 17,000 people are estimated to lose
their battle with a primary brain or CNS tumor this year.
According to GBI Research, global revenues for the cancer
vaccine market are forecast to grow from $2.5 billion in 2015 to
$7.5 billion in 2022, which represents a compound annual growth
rate (CAGR) of 16.93%.
Innovest Recently Signs LOI to Acquire 20% Stake in StemVax
Therapeutics, A Brain Cancer Vaccine Developer
Innovest Global recently announced that it has signed a Letter
of Intent to acquire a 20% stake in StemVax Therapeutics,
a biotechnology company that is currently developing a
brain cancer vaccine.
The StemVax Glioblast (SVX-GB) cancer vaccine is being designed
and formulated to help restore a patient’s immune system in order
to fight off existing cancer cells within the body.
The vaccine is designed to fight
against glioblastoma brain cancers, which is the same
type of tumor that is currently affecting Arizona Senator John
McCain.
In other news, Innovest also recently announced that its
Innovest Energy Group has completed the previously-announced LOI
acquisition of H.P. Technologies, an energy procurement
company that is generating annual revenues of $1.2 million.
Furthermore, H.P.’s owner, Dennis Giancola, has joined the Innovest
Energy Group division.
Entering into the second quarter, Innovest Global is now
generating baseline quarterly revenues of around $800,000, just
from its Commercial & Industrial Energy division alone. This
comes as management is scheduled to officially launch its Biotech
& Health Sciences division this Spring.
Management announced in its March shareholder
update that it has engaged NMS, Inc. to conduct a two-year
audit on the company’s financials. The PCAOB-compliant firm has a
strong 30-year track record of success and has a staff of 40
employees. This effectively begins the company’s plan to uplist to
higher exchanges, such as the OTCQX and eventually the NASDAQ or
NYSE.
Innovest Global, Inc. was also recently featured on the
inaugural episode of Spotlight Growth Live, a video web series
that focuses on emerging growth companies.
For more information on Innovest Global, Inc.,
please
visit http://innovestglobal.com and http://spotlightgrowth.com/index.php/2018/04/09/healthcare-sector-sees-rosy-outlook-as-global-health...
SpotlightGrowth.com is a digital hub for micro-caps,
small-caps, crowdfunding, cryptocurrency, and other emerging growth
investors. SpotlightGrowth.com serves as our media
subsidiary and provides insights on small cap companies.
Disclaimer:
Spotlight Growth is compensated, either directly or via a third
party, to provide investor relations services for its
clients. Spotlight Growth creates exposure for companies
through a customized marketing strategy, including design of
promotional material, the drafting and editing of press releases
and media placement.
All information on featured companies is provided by the
companies profiled, or is available from public sources. Spotlight
Growth and its employees are not a Registered Investment Advisor,
Broker Dealer or a member of any association for other research
providers in any jurisdiction whatsoever and we are not qualified
to give financial advice. The information contained herein is based
on external sources that Spotlight Growth believes to be reliable,
but its accuracy is not guaranteed. Spotlight Growth may
create reports and content that has been compensated by a company
or third-parties, or for purposes of self-marketing. Spotlight
Growth was compensated two thousand five hundred dollars cash and
fifty thousand restricted shares for the creation and dissemination
of this content.
This material does not represent an investment solicitation.
Certain statements contained herein constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Such statements may include, without
limitation, statements with respect to the Company’s plans and
objectives, projections, expectations and intentions. These
forward-looking statements are based on current expectations,
estimates and projections about the Company’s industry,
management’s beliefs and certain assumptions made by
management.
The above communication, the attachments and external Internet
links provided are intended for informational purposes only and are
not to be interpreted by the recipient as a solicitation to
participate in securities offerings. Investments referenced
may not be suitable for all investors and may not be permissible in
certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and
employees may have bought or sold or may buy or sell shares in the
companies discussed herein, which may be acquired prior, during or
after the publication of these marketing materials. Spotlight
Growth, its affiliates, officers, directors, and employees may sell
the stock of said companies at any time and may profit in the event
those shares rise in value. For more information on our
disclosures, please
visit: http://spotlightgrowth.com/index.php/disclosures/
Contact: Matt Rego 9165257147 mrego@spotlightgrowth.com